Dominique Tschudi Meyer

u-blox AG supplies positioning and wireless semiconductors and modules for the automotive, industrial, and consumer markets. It offers cellular and short range radio such as multiradio, wi-fi, bluetooth, and V2X. The company was founded Daniel Ammann, Jean-Pierre Wyss, Gerhard Troester, and Andreas Thiel in 1997 and is headquartered in Thalwil, Switzerland.

Axovan AG conducts biopharmaceutical research and develops pharmaceuticals. Active in pharmaceutical research and development, it focuses on the family of drug targets called G protein-coupled receptors (GPCRs), which are involved in a number of pathologies. It has developed a validated GPCR-based chemical library through its proprietary chem-informatics platform AXADDIS. Its lead product, clasozentan, is an intravenous endothelin receptor antagonist optimized for treating cerebral diseases. It is partnering non-core indication projects (pain, metabolic diseases, inflammation) at earlier stages. The company was founded in 2000 and is headquartered in Allschwil, Switzerland.

Chemgineering Holding AG provides technology, consulting and engineering services in fields of pharmaceuticals, biotechnology, and bulk chemicals. The company was founded in 1996 and is headquartered in Münchenstein, Switzerland.

Institut Straumann AG operates a dentistry group. It engages in the research, development and manufacturing dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions. The company is headquartered in Basel, Switzerland.

Swiss-American Chamber of Commerce is an organization that advocates for Swiss, American, and multinational business interests. The non-profit company is based in Zurich, Switzerland. The Swiss company is active in all three major regions of Switzerland, organizing events and conducting comprehensive studies on business-related topics. The organization's special committees provide valuable input into its operations, and its flagship publication, the Yearbook, contains a member directory and a comprehensive collection of facts and figures on Swiss-U.S. business relations. Martin M. Naville has been the CEO of the company since 2004.

Endeavour Vision SA (EV) is an independent venture capital firm headquartered in Geneva. EV traces their origins back to 1989 through the convergence of the Vision Capital European team and the Swiss VC firm, Endeavour. EV was co-founded in 2000 by Sven Lingjaerde and Damien Tappy. The firm specializes in providing funding for entrepreneurs in life sciences, biotech, medtech, cleantech and information technology. EV operates in close cooperation with Genevest, an independent investment vehicle which has reached the divestment stage. Their investors in the funds they advise are industrial corporations, family offices, global institutional investors and business leaders in the technology and investment industry.

Econis AG engages in the provision of Information Technology services. It offers IT outsourcing, econis private cloud, FinTech platform, and SAP HANA in-memory computing. The company was founded in 1997 and is headquartered in Dietikon, Switzerland.

OncoEthix SA operates as a clinical stage biotechnology company which develops cancer drugs. Its products include OTX008, OTX015, and OTX009. The company was founded by Esteban Cvitkovic, Jeanne Kay Noel, Yves Paternot, and Patrice Herait in March 2007 and is headquartered in Luzern, Switzerland.

Economiesuisse operates as a trade industry association. The company is headquartered in Zurich, Switzerland.

Accenture AG provides services and solutions in the areas of strategy, consulting, digital, technology, and operations. The company was founded on August 5, 1983 and is headquartered in Zurich, Switzerland.

Bachofen AG engages in the supply of industrial automation technology solutions. It offers components, assemblies, and systems used in sector-specific applications such as production sites and system operators in the chemical, medical technology, automotive, machines and installations, construction, and transport industries. The firm also provides services, which include consuting, logistics, quality management, testing, and installation. The company was founded in 1945 and is headquartered in Uster, Switzerland.

BLR & Partners AG is a venture capital and private equity firm based in Zurich, Switzerland. The Swiss company was founded by Ulrich Jakob Looser and the CEO is Mikael Ramvall.

Fostag Formenbau AG is a private company based in Stein am Rhein, Switzerland. The Swiss company provides services such as advice, planning, construction, production, acceptance, training, and service in the field of form building. Fostag Formenbau specializes in product areas such as medicine, pharma, labor, packing, and special applications. The company was founded in 1955, and Markus Mühlemann has been the CEO of the company since 1998.

Baitella AG specializes in individualized holding system solutions with central clamping unit. Its products include endoscope and instrument holder for surgery, patient arm positioning, anesthetic and breathing tubes, monitoring monitors, as well as holders for gauges, optics, photography, and video. The company was founded by Carlo Baitella in 1958 and is headquartered in Zurich, Switzerland.

BLR Capital AG is an investment advisor that focuses on industrially driven value creation for small and medium-sized companies in the industrial and services sectors. The private company is based in Zurich, Switzerland and currently has around 20 partners and employees. BLR Capital invests in medium-sized companies in German-speaking countries and sees itself as an active partner with the aim of achieving sustainable increases in value for the Swiss company and its investors. The company has managed over 30 companies in its own investment portfolio and as an active portfolio manager over the last 5 years. BLR Capital is committed to long-term and sustainable considerations with the focus on the future of the company and its stakeholders. Founded in 2009 as a subsidiary of BLR Partners, BLR Capital has been the "operative" unit since 2018, which implements a wide range of its own projects and services for third parties.

ZuriMED Technologies AG is a Swiss company that specializes in biomaterial research and translational development. The company is based in Zurich, Switzerland. The company was founded in 2015. The CEO is Xiang Li.